sulfinpyrazone has been researched along with Oliguria in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Oliguria: Decreased URINE output that is below the normal range. Oliguria can be defined as urine output of less than or equal to 0.5 or 1 ml/kg/hr depending on the age.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perez Mijares, R | 1 |
| Praga Terente, M | 1 |
| Lopez de Novales, E | 1 |
1 other study available for sulfinpyrazone and Oliguria
| Article | Year |
|---|---|
Oliguric acute renal failure after treatment with sulfinpyrazone.
Topics: Acute Kidney Injury; Humans; Male; Middle Aged; Oliguria; Sulfinpyrazone | 1983 |